Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 18, 2020 10:05 ET | Source: PMI

Global Non-alcoholic Steatohepatitis Biomarkers Market Accounted for US$ 556.6 Billion in 2019 and is Estimated to be US$ 8177.9 Billion by 2029 and is Anticipated to Register a CAGR of 31.3%

Covina, CA, Aug. 18, 2020 (GLOBE NEWSWIRE) -- The report "Global Non-alcoholic Steatohepatitis Biomarkers Market, By Type (Serum Biomarkers, Hepatic Fibrosis Biomarkers, Apoptosis Biomarkers,...